Biodexa Pharmaceuticals (BDRX) - שיעור רווח גולמי

סמלים רשמיים של חברת biodexapharma.com (BDRX)

The current gross margin level of Biodexa Pharmaceuticals (BDRX), which develops unique drug delivery methods for brain oncology, demonstrates financial momentum. The value of 0.00 shows the latest figure for this metric. A stable authority in the biotech sector is complemented by a risk mitigation strategy via targeted chemotherapy, which minimizes toxic impact on the patient's body.

Biodexa Pharma - שולי רווח גולמי BDRX (תקופה 28.04.2023 - 20.11.2026)

פילוחים אנליטיים ודוחות נתונים של חברת Biodexa Pharma (BDRX)

- שווי שוק ותחזית יעד של אנליסטים:
ניתוח בסיסי של החברה:BDRX, Biodexa Pharmaceuticals
מוצר המיוצר על ידי Biodexa

Gross margin measures production efficiency by determining the profit share after deducting direct costs of product creation. Analyzing the gross margin ratio allows for an assessment of a business's ability to generate cash flow to cover operating expenses and investments. For Biodexa Pharmaceuticals (BDRX), this metric confirms the high added value of orphan drugs, providing pricing power within the narrow neuro-oncology segment.